Opioid receptor-mediated control of acetylcholine release in human neocortex tissue

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 354, Issue 5, 1996, Pages 586-592

  Feuerstein, T J ^a   Gleichauf, O ^a   Peckys, D ^a   Landwehrmeyer, G B ^a   Scheremet, R ^a   Jackisch, R ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Acetylcholine release; Endogenous opioids; Human neocortex; Interneurons; Opioid receptors

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; BACLOFEN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; MORPHINE; MUSCIMOL; NALOXONE; NALTRINDOLE; NORBINALTORPHIMINE; OPIATE AGONIST; OPIATE ANTAGONIST; OPIATE RECEPTOR; TILIDINE;

ACETYLCHOLINE RELEASE; ARTICLE; CHOLINERGIC NERVE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; NEOCORTEX;

EID: 0029990884     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00170832     Document Type: Article

References (34)

1. Anger WK (1991) Animal test systems to study behavioral dysfunctions of neurodegenerative disorders. Neurotoxicology 12:403-413
2. Birch PJ, Hayes AG, Sheehan MJ, Tyers MB (1987) Norbinaltorphimine: antagonist profile at κ opioid receptors. Eur J Pharmacol 144:405-408
3. 1 opiate binding sites. Eur J Pharmacol 128:303-304
4. Coyle JT, Price DL, DeLong MR (1983) Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219:1184-1190
5. Deuchars J, Thomson AM (1995) Single axon fast inhibitory postsynaptic potentials elicited by a sparsely spiny interneuron in rat neocortex. Neuroscience 65:935-942
6. Domino EF (1979) Opiate interactions with cholinergic neurons. Adv Biochem Psychopharmacol 20:339-355
7. Evans CJ, Keith DJ, Morrison H, Magendzo K, Edwards RH (1992) Cloning of a δ opioid receptor by functional expression. Science 258:1952-1955
8. Feuerstein TJ, Bammert J, Meyer DK (1987) Endogenous agonists may change the concentration-response curves of exogenous agonists: source of quantitative information about the endogenous tone. Biol Cybernetics 56:419-429
9. Feuerstein TJ, Dooley DJ, Seeger W (1990) Inhibition of norepinephrine and acetylcholine release from human neocortex by ω-conotoxin GVIA. J Pharmacol Exp Ther 252:778-785
10. 2+ entry via L-type channels for induction of serotonin release from rabbit hippocampus. Eur J Pharmacol 198:37-42
11. Feuerstein TJ, Lehmann J, Sauermann W, v. Velthoven V, Jackisch R (1992) The autoinhibitory feedback control of acetylcholine release from human neocortex tissue. Brain Res 572:64-71
12. 2-adrenoceptors on serotonergic nerve endings in human and rat neocortex. J Neurochem 61:474-480
13. Feuerstein TJ, Sauermann W, Allgaier C, Agneter E, Singer EA (1994) New insights into receptor theory, as provided by an artificial partial agonist made-to-measure. Naunyn-Schmiedeberg's Arch Pharmacol 350:1-9
14. Goldstein A, Naidu A (1989) Multiple opioid receptors: ligand selectivity profiles and binding site signatures. Mol Pharmacol 36:265-272
15. Izquierdo I (1990) Acetylcholine release is modulated by different opioid receptor types in different brain regions and species. Trends Pharmacol Sci 11:179-180
16. Jackisch R (1991) Regulation of neurotransmitter release by opiates and opioid peptides in the central nervous system. In: Feigenbaum J, Hanani M (eds) Presynaptic regulation of neurotransmitter release: a handbook, Freund, Tel Aviv, pp 551-592
17. Jackisch R, Geppert M, Brenner AS, Illes P (1986) Presynaptic opioid receptors modulating acetylcholine release in the hippocampus of the rabbit. Naunyn- Schmiedeberg's Arch Pharmacol 332:156-162
18. Jackisch R, Hotz H, Hertting G (1993) No evidence for presynaptic opioid receptors on cholinergic, but presence of κ-receptors on dopaminergic neurons in the rabbit caudate nucleus: involvement of endogenous opioids. Naunyn Schmiedeberg's Arch Pharmacol 348:234-241
19. Kieffer BL, Befort K, Gaveriaux RC, Hirth CG (1994) The δ-opioid receptor: Isolation of a cDNA by expression cloning and pharmacological characterization. Proc Natl Acad Sci USA 91:12048-12052
20. Kosterlitz HW, Paterson SJ, Robson LE, Traynor JR (1987) Effects of cations on binding, in membrane suspensions, of various opioids at m-sites of rabbit cerebellum and k-sites of guinea-pig cerebellum. Br J Pharmacol 91:431-437
21. Lapchak PA, Araujo DM, Collier B (1989) Regulation of endogenous acetylcholine release from mammalian brain slices by opiate receptors: hippocampus, striatum and cerebral cortex of guinea-pig and rat. Neuroscience 31:313-325
22. Leslie FM (1987) Methods used for the study of opioid receptors. Pharmacol Rev 39:197-249
23. McGaugh JL (1989) Involvement of hormonal and neuromodulatory systems in the regulation of memory storage. Annu Rev Neurosci 12:255-287
24. Paterson SJ, Robson LE, Kosterlitz HW (1983) Classification of opioid receptors. Br Med Bull 39:31-36
25. Portoghese PS, Sultana M, Takemori AE (1988) Naltrindole, a highly selective and potent non-peptide d-opioid receptor antagonist. Eur J Pharmacol 146:185-186
26. Rogers H, Hayes AG, Birch PJ, Traynor JR, Lawrence AJ (1990) The selectivity of the opioid antagonist, naltrindole, for d-opioid receptors. J Pharm Pharmacol 42:358-359
27. Sanger DJ, Joly D (1990) Psychopharmacological strategies in the search for cognition enhancers. Pharmacopsychiatry 2:70-74
28. Schulz R, Blasig J, Wuster M, Herz A (1978) The opiate-like action of tilidine is mediated by metabolites. Naunyn-Schmiedeberg's Arch Pharmacol 304:89-93
29. Takemori AE, Ho BY, Naeseth JS, Portoghese PS (1988) Nor-binaltorphimine, a highly selective k-opioid antagonist in analgesic and receptor binding assays. J Pharmacol Exp Ther 246:255-258
30. Taquet H, Javoy AF, Mauborgne A, Benoliel JJ, Agid Y, Legrand JC, Tramu G, Cesselin F, Hamon M (1988) Biochemical mapping of cholecystokinin-, substance P-, [Met]enkephalin-, [Leu]enkephalin- and dynorphin A (1-8)-like immunoreactivities in the human cerebral cortex. Neuroscience 27:871-883
31. Thompson RC, Mansour A, Akil H, Watson SJ (1993) Cloning and pharmacological characterization of a rat m-opioid receptor. Neuron 11:903-913
32. Turner AJ, Matsas R, Kenny AJ (1985) Are there neuropeptide-specific peptidases? Biochem Pharmacol 34:1347-1356
33. Vonvoigtlander PF, Lahti RA, Ludens JH (1983) U-50,488: a selective and structurally novel non-μ (k) opioid agonist. J Pharmacol Exp Ther 224:7-12
34. Westlake WJ (1981) Response to bioequivalence testing - a need to rethink. Biometrics 37:591-593